Related by context. All words. (Click for frequent words.) 69 ICD implants 68 antiplatelet therapies 68 ICD implantation 68 oral anticoagulation 68 antithrombotic therapy 67 VTE prophylaxis 67 lipid lowering therapy 66 biologic DMARDs 66 aldosterone antagonists 66 warfarin therapy 66 aldosterone antagonist 65 LDB CPR 65 elective PCI 65 anticoagulation therapy 65 preoperative chemotherapy 65 resynchronization therapy 65 antiarrhythmic drug 65 thrombolytic therapy 65 coronary stenting 65 antioxidant supplementation 65 MADIT II 65 neo adjuvant chemotherapy 65 revascularization procedure 65 stratifying patients 65 PASI scores 65 Zevalin consolidation 64 antimicrobial prophylaxis 64 β blockers 64 patients undergoing CABG 64 antithrombotic therapies 64 defibrillator implant 64 angiographic outcomes 64 myocardial infarctions MIs 64 antiangiogenic therapy 64 clot busting therapy 64 oral anticoagulant therapy 64 biventricular pacing 64 antiplatelet medication 64 Carotid endarterectomy 64 NATRECOR R 64 attain statistical significance 64 CYPHER Stent 64 thromboprophylaxis 64 nonvertebral fracture 64 multivessel disease 64 adjuvant therapies 64 cardiac resynchronization 63 prospectively stratified 63 cardiac resynchronisation therapy 63 NNT = 63 bolus dose 63 rFVIIa 63 coronary intervention 63 pacemaker implantation 63 dose Iluvien 63 postoperative chemotherapy 63 BENICAR HCT 63 fibrinolytic therapy 63 intravenous diuretics 63 coronary CTA 63 myocardial viability 63 revascularization procedures 63 perioperative morbidity 63 PNH patients 63 oncologic outcomes 63 postoperative pulmonary 63 samalizumab 63 refractory angina 62 aromatase inhibitor therapy 62 OPCAB 62 noncardiovascular mortality 62 Kaplan Meier estimate 62 venous thromboembolic disease 62 riociguat 62 debulking surgery 62 antiarrhythmic drugs 62 HbA 1c levels 62 inotropic 62 Hb A1C 62 NYHA functional class 62 carotid artery stenting 62 antiplatelet therapy 62 bi ventricular pacing 62 hemoglobin A1c levels 62 chemoradiotherapy 62 eculizumab therapy 62 alteplase 62 reperfusion therapy 62 ratio ICER 62 NATRECOR ® 62 thoracoscopic lobectomy 62 MTWA testing 62 rt PA 62 rtPA 62 HeartNet 62 antiplatelet medications 62 postoperative atrial fibrillation 62 thrombus aspiration 62 postoperative mortality 62 HbA1C levels 62 TURBT 62 postoperative AF 62 TAVR 62 IOP lowering 62 immunosuppression therapy 62 comorbid conditions 62 ablative therapy 62 postoperative radiotherapy 62 carotid artery stenting CAS 61 DES implantation 61 LV dysfunction 61 perioperative mortality 61 MGd 61 pegylated interferon alfa 2b 61 Carotid artery stenting 61 randomizing patients 61 eplerenone 61 chronic hemodialysis 61 metformin Glucophage 61 APTIVUS ritonavir 61 coronary revascularization procedures 61 mycophenolate mofetil 61 FFR guided 61 warfarin anticoagulation 61 epidural analgesia 61 platelet reactivity 61 antiplatelet agents 61 Q#IR 61 MAGE A3 ASCI 61 glycated hemoglobin levels 61 gadobutrol 61 GnRH agonists 61 atherosclerotic renal artery stenosis 61 immunosuppressive regimens 61 IFN alfa 61 beta blocker therapy 61 efficacy evaluable 61 symptomatic VTE 61 DAPT 61 CRT Ds 61 coronary revascularization 61 CYP#D# inhibitor 61 anticoagulant therapy 61 CYPHER ® 61 surrogate endpoint 61 inotropic therapy 61 pain palliation 61 therapeutic regimens 61 PRADAXA 61 LAGB 61 antiplatelet drugs 61 methotrexate monotherapy 61 hemodialysis patients 61 CPAP adherence 61 subgroup analyzes 61 ARIXTRA 61 androgen deprivation 61 thrombotic complications 61 aspirin clopidogrel 61 antibiotic prophylaxis 61 TWYNSTA 61 carotid stenting 61 coronary artery bypass grafts 61 COR Analyzer 61 sargramostim 61 PSA nadir 61 APTIVUS r 61 glycosylated hemoglobin levels 61 REMINYL ® 61 DLQI 61 nonrandomized 60 TAXUS Stent 60 anticlotting drugs 60 Rheos System 60 prelicensure 60 Secondary efficacy endpoints 60 inhaled iloprost 60 MVax 60 chemoprevention trials 60 ER CHOP 60 adenoma recurrence 60 Surgical excision 60 intracranial stenosis 60 cytoreductive nephrectomy 60 glycoprotein IIb IIIa inhibitors 60 TroVax ® 60 guideline concordant 60 dose clopidogrel 60 lipid lowering agents 60 anticoagulation 60 ß blockers 60 intensive lipid lowering 60 anti coagulant therapy 60 teriflunomide 60 NCCN guidelines 60 tissue plasminogen activator tPA 60 testosterone supplementation 60 drug eluting coronary stents 60 prospectively defined 60 undergoing CABG 60 SCIg 60 ximelagatran 60 renal transplants 60 antipsychotic prescribing 60 adverse cytogenetics 60 intracerebral haemorrhage 60 renal denervation 60 ticlopidine 60 relapsed MM 60 HSCT 60 symptomatic paroxysmal AF 60 argatroban 60 ECD kidneys 60 angioplasty stenting 60 pharmacologic stress 60 coronary interventions 60 PressureWire 60 untreated OSA 60 BEXXAR Therapeutic Regimen 60 inhospital mortality 60 ZOLINZA 60 prognostic variables 60 cardiac perfusion 60 paroxysmal AF 60 ofpatients 60 lipid lowering medication 60 methotrexate therapy 60 dexmedetomidine 60 CRT ICD 60 everolimus eluting stents 60 echocardiographic parameters 60 pamidronate 60 suboptimal adherence 60 carotid revascularization 60 antihypertensive medications 60 hsCRP levels 60 serum phosphate levels 60 epoetin therapy 60 hypofractionated radiation 60 antidiabetic medications 60 HIPEC 60 opioid analgesia 60 agomelatine 60 antithrombotics 60 poor metabolizers 60 tachyarrhythmia 60 intravenous cyclophosphamide 60 hepatic resection 60 aromatase inhibitors AIs 60 atrial arrhythmias 60 medication nonadherence 60 Subgroup analyzes 60 CABG surgeries 60 dose escalation phase 60 ICD implantations 60 dual antiplatelet 60 azacitidine 60 antithrombotic 60 dose atorvastatin 60 nonpharmacologic 60 intravesical therapy 60 perioperatively 60 FOLFOX4 60 normothermia 60 atherothrombotic disease 60 intravenous tPA 60 corticosteroid dose 60 Influenza vaccination 60 non valvular atrial 60 FXIII 60 dobutamine 59 postoperative complication 59 binary restenosis 59 curative resection 59 NovoTTF 59 tumor histology 59 Doxil ® 59 cerebrovascular events 59 divalproex sodium 59 defibrillator implantation 59 dopaminergic therapy 59 SYNTAX trial 59 Subgroup analysis 59 chemoradiation therapy 59 Octreolin 59 UA NSTEMI 59 TAXUS Liberte Stent 59 GnRH agonist 59 autonomic dysfunction 59 percutaneous intervention 59 GP IIb IIIa inhibitors 59 tamoxifen Nolvadex ® 59 conventional angiography 59 pyridostigmine 59 GAMMAGARD 59 revascularizations 59 prespecified secondary 59 Exforge HCT 59 chemoembolization 59 MitraClip device 59 eptifibatide 59 adult chronic ITP 59 canakinumab 59 ICD shocks 59 analgesic medications 59 liver transplant recipients 59 APTIVUS R 59 adjuvant radiotherapy 59 androgen suppression 59 recurrent ischemia 59 INTERCEPT platelets 59 vaginal hysterectomy 59 pulmonary artery catheters 59 antihypertensive medication 59 serum phosphorous 59 androgen ablation 59 periodically reassessed 59 pulmonary artery catheterization 59 RBC transfusions 59 isolated systolic hypertension 59 immunosuppressive therapies 59 lipid lowering medications 59 NIHSS score 59 antiplatelets 59 Colorectal cancer screening 59 Cardiac resynchronization therapy 59 genotypic resistance 59 immunosuppressant therapy 59 HORIZONS AMI trial 59 relapsing MS 59 Drug eluting stent 59 postprocedure 59 antibiotic regimens 59 carotid endarterectomy CEA 59 insulin detemir 59 TNF alpha inhibitor 59 thrombolytic agents 59 treat NNT 59 APEX AMI 59 QTc prolongation 59 recurrent VTE 59 neoadjuvant treatment 59 ticagrelor Brilinta 59 Vimpat R 59 ejection fractions 59 HAQ DI 59 postdischarge 59 limiting generalizability 59 NTx ® -# 59 EuroSCORE 59 fibrinolysis 59 salmeterol fluticasone 59 Cypher Stent 59 CYPHER R Sirolimus eluting 59 unruptured aneurysm 59 bronchial thermoplasty 59 clevidipine 59 Randomized clinical trials 59 Inspra 59 convenient dosing regimen 59 inhospital 59 nucleoside naive patients 59 splenectomized patients 59 triglyceride concentrations 59 Coronary Artery Bypass Graft 59 symptomatic hyponatremia 59 dosing frequency 59 PTNS 59 colonoscopic 59 SIMPADICO 59 vascular insufficiency 59 glycemic variability 59 cranial radiation 59 XL# SAR# 59 LNG IUS 59 paricalcitol 59 prolongs survival 59 VADT 59 definite stent thrombosis 59 STEMI patients 59 CANCIDAS 59 maximal doses 59 certolizumab 59 cinacalcet 59 chronic periodontitis 59 sevelamer 59 warfarin dosage 59 histological subtype 59 coexisting illnesses 59 Thorough QT 59 chronic thromboembolic pulmonary 59 octreotide LAR 59 palivizumab 59 PSADT 59 dual antiplatelet therapy 59 fondaparinux 59 glomerular filtration 59 CIMZIA ™ 59 chemotherapeutic regimen 59 dacarbazine chemotherapy 59 VT VF 59 concomitant medications 59 gp# vaccine 59 aldosterone antagonist therapy 59 R0 resection 59 immunosuppressant medication 59 retrospective cohort 59 leukoreduction 59 EGFR mutation status 59 Procoralan 59 radiochemotherapy 59 oral hypoglycemic agents 59 atypical antipsychotic medications 59 postoperative morbidity 58 PK PD modeling 58 hip resurfacing arthroplasty 58 glucocorticoid therapy 58 sustained virological response 58 antidiabetic drugs 58 acute STEMI 58 morphometric vertebral fractures 58 relapsed SCLC 58 Ceplene/IL-2 58 prognostic indicators 58 standard chemotherapy regimen 58 ACUITY trial 58 antianginal 58 KRAS mutations occur 58 upper gastrointestinal bleeding 58 empiric therapy 58 carotid artery blockage 58 cilostazol 58 letrozole Femara 58 pelvic lymphadenectomy 58 STRIDE PD 58 renal biopsy 58 tele ICU 58 NeuroFlo 58 WBPA 58 thienopyridine 58 Kaplan Meier analysis 58 Accelerated Partial Breast Irradiation 58 IPAH 58 comorbid illnesses 58 cerebral angiography 58 thromboembolic disease 58 low dose Iluvien 58 Thalomid ® 58 FOLFIRINOX 58 fragility fracture 58 pharmacological therapies 58 implantable cardioverter defibrillator ICD 58 transcatheter aortic valve implantation 58 tapentadol ER 58 residual confounding 58 cardiac resynchronization therapy 58 obstructive CAD 58 complete cytogenetic response 58 nondiabetic patients 58 interferon ribavirin 58 GENASIS trial 58 galiximab 58 biochemical recurrence 58 Pneumococcal vaccination 58 sacral nerve stimulation 58 KRAS status 58 nonischemic 58 myocardial reperfusion 58 subcutaneous insulin 58 predialysis 58 ibandronate 58 BEXXAR therapeutic regimen 58 conditional logistic regression 58 noncancer 58 treprostinil 58 recurrent venous thromboembolism 58 Allovectin 7 ® 58 primary percutaneous coronary 58 bevacizumab Avastin Genentech 58 Stretta procedure 58 adjuvant radiation 58 EDSS score 58 timepoints 58 morbidity mortality 58 dose statin therapy 58 concomitant antibiotics 58 statin therapy 58 dalteparin 58 nonoperative treatment 58 cisplatin chemotherapy 58 carotid plaque 58 antihypertensive therapy 58 FROVA 58 opioid prescribing 58 levosimendan 58 percutaneous interventions 58 solid organ transplantation 58 interventional cardiac 58 perioperative complications 58 nonischemic cardiomyopathy 58 lipid lowering therapies 58 ARB telmisartan 58 allogeneic HSCT 58 sipuleucel T 58 hepatorenal syndrome 58 diagnostic modality 58 preserved ejection fraction 58 Minimally invasive procedures 58 intravitreal injections 58 heterozygous FH 58 YERVOY 58 TMP SMX 58 baseline HbA1c 58 microbiologically evaluable 58 thromboembolism 58 AGGRASTAT ® tirofiban hydrochloride 58 VIDAZA azacitidine 58 venous thromboembolisms 58 Telintra 58 subthreshold depression 58 bezafibrate 58 clopidogrel Plavix 58 clopidogrel pretreatment 58 intensive statin therapy 58 Nesiritide 58 ACCORD Lipid 58 osteoporotic vertebral compression fractures 58 CMV disease 58 cranial irradiation 58 thromboembolic complications 58 Coronary CTA 58 gefitinib Iressa 58 paclitaxel eluting stents 58 Zemplar Capsules 58 atrial fibrillation ablation 58 thiazide diuretic 58 adjuvant therapy 58 ispinesib administered 58 K DOQI guidelines 58 oral antidiabetes 58 renoprotective 58 coronary arteriography 58 rhGH 58 DVT PE 58 PCIs 58 tirofiban 58 INS# [002] 58 azilsartan medoxomil 58 transdermal estrogen 58 systemic immunosuppressive drugs 58 balloon brachytherapy 58 induce remission 58 oxymorphone ER 58 UPPP 58 implantable cardioverter defibrillators ICDs 58 TNF antagonist 58 ischemic cardiomyopathy 58 MMSE score 58 hepatectomy 58 bypass grafting 58 glycoprotein IIb IIIa inhibitor 58 inhaled treprostinil 58 mg/m2 cohort 58 FDG PET 58 HIV HCV coinfected 58 bowel resection 58 IV bisphosphonates 58 stable angina 58 tolterodine 58 Operative mortality 58 virological response 58 troponins 58 lipid lowering drugs 58 AVONEX PEN 58 preoperative evaluation 58 FFR guided treatment 58 bariatric surgical 58 NSABP C 58 pharmacologic therapy 58 liposomal doxorubicin 58 A1c levels 58 recurrent glioblastoma multiforme 58 pulmonary artery banding 58 unfractionated heparin 58 inhaled nitric oxide 58 atorvastatin #mg 58 probiotic supplementation 58 electrical cardioversion 58 microdebrider 58 inhaled glucocorticoids 58 LMWH 58 drotrecogin alfa activated 58 extubation 58 Meta analyzes 58 UVIDEM 58 multivariable adjustment 58 spiral computed tomography 58 carotid stents 58 concurrent chemoradiation 58 curative therapy 58 myocardial revascularization 58 SCD HeFT 58 unstable angina UA 58 noncardiac 58 atherothrombotic events 58 postoperative infections 58 ICSs 58 nicardipine 58 procedural sedation 58 EDARBI 58 EchoCRT 58 biventricular 58 corticosteroid therapy 58 ATACAND 58 inhaled corticosteroid therapy 58 bioprosthetic valve 57 lowering systolic blood 57 interventional therapies 57 neoadjuvant chemotherapy 57 cART 57 thrombolytics 57 basal bolus regimen 57 neoadjuvant therapy 57 PICSO ® 57 sociodemographic characteristics 57 figitumumab 57 ALGRX 57 cystoscopic 57 chronic prostatitis chronic 57 Hydroxyurea 57 cardiac revascularization 57 Aspergillus infections 57 NSTEMI 57 FFR measurements 57 aspirin beta blockers 57 oral antiplatelet therapy 57 MYCAMINE 57 Certican 57 XIENCE V PROMUS Stent 57 clinically meaningful efficacy 57 chronic myocardial ischemia 57 olmesartan 57 iniparib 57 GVAX Pancreas Vaccine 57 liver resection 57 laparoscopic bariatric surgery 57 intravenous tissue plasminogen 57 Provacel 57 inhaled budesonide 57 Reynolds Risk Score 57 randomized multicenter Phase III 57 postmenopausal hormone 57 vildagliptin 57 asymptomatic hyperuricemia 57 anticholinergic agents 57 defibrillator CRT D 57 Tekamlo 57 cytoreduction 57 immunosuppressive regimen 57 NAVISTAR R 57 TAXUS VI 57 FRAGMIN R 57 PLX STROKE targeting 57 systemic corticosteroid 57 drug eluting stent DES 57 rufinamide 57 HuLuc# 57 Torisel 57 neurocognitive function 57 anemia hemoglobin 57 NPH insulin 57 reinfarction 57 Proleukin 57 systolic dysfunction 57 antidiabetic medication 57 xanthine oxidase inhibitor 57 colon capsule endoscopy 57 epidural steroid injection 57 inhaled bronchodilators 57 patients 57 sotalol 57 patients undergoing percutaneous 57 sirolimus eluting stents 57 null responder 57 OHR/AVR# 57 GP IIb IIIa inhibitor 57 Stabilimax NZ 57 immunomodulatory therapy 57 antihypertensive agents 57 radioiodine therapy 57 ventilatory 57 invasive coronary angiography 57 calcineurin inhibitor 57 ARCOXIA 57 BEXXAR 57 Pegasys peginterferon alfa 2a 57 antiarrhythmic 57 Aprotinin 57 estimated GFR 57 AZOR 57 unsedated colonoscopy 57 NAbs 57 lymphadenectomy 57 ENDEAVOR clinical 57 cerebral perfusion 57 maximally tolerated dose 57 nonadherence 57 Febrile neutropenia 57 5-FU/LV 57 maximally tolerated 57 stenting procedures 57 noninvasive outpatient 57 neutrophil counts 57 dosing cohort 57 p# biomarker 57 Combo Stent 57 Therapeutic hypothermia 57 colorectal adenoma 57 pancreatic adenocarcinoma 57 5-fluorouracil/leucovorin 57 thrombocytopenic 57 baseline LDH 57 pharmacodynamic parameters 57 AChE inhibitors 57 intravascular stent 57 OMS# 57 secondary efficacy endpoint 57 osteoporotic compression fractures 57 macrovascular disease 57 trastuzumab Herceptin ® 57 vasomotor symptoms 57 Lung transplantation 57 desvenlafaxine succinate 57 NSTE ACS 57 posttransplant 57 severe asthma exacerbations 57 Cardiopulmonary bypass 57 external beam radiotherapy 57 AF ablation procedures 57 inotropes 57 Inhaled nitric oxide 57 remifentanil 57 intravenous bisphosphonates 57 inflammatory biomarkers 57 Aggrastat ® tirofiban hydrochloride 57 PONV 57 frameless radiosurgery 57 VATS lobectomy 57 periprocedural 57 endocrine therapies 57 MoxDuo TM IR 57 ABSORB trial 57 sunitinib malate 57 BYSTOLIC 57 MERLIN TIMI 57 carotid bruit 57 confirmatory clinical 57 Kidney transplantation 57 failure NYHA 57 cardioverter defibrillator 57 arterial thromboembolic events 57 stereotactic radiotherapy 57 oxycodone CR 57 lenalidomide dexamethasone 57 acromegalic patients 57 doxorubicin docetaxel 57 AGILECT R 57 fluvastatin 57 aldosterone hormone 57 CINQUIL 57 prophylactic antibiotic 57 Radical prostatectomy 57 Surgical resection 57 noncardiac surgery 57 mesalamine granules 57 HAART initiation 57 reoperations 57 Perforomist Inhalation Solution 57 non selective NSAIDs 57 defibrillators CRT Ds 57 decompensated heart failure 57 TYGACIL 57 psychiatric comorbidity 57 TORISEL 57 carotid stenosis 57 underwent liver transplantation 57 immunosuppressive medications 57 antiangiogenic drugs 57 percutaneous vertebroplasty 57 darbepoetin alpha 57 gynecologic procedures 57 randomized blinded 57 APTIVUS 57 NEVO ™ 57 pretest probability 57 transrectal ultrasound guided 57 HER2 expression 57 hemodynamically stable 57 Spectranetics laser 57 EECP therapy 57 Abbott Trilipix 57 BeneFIX 57 Angiomax monotherapy 57 death reinfarction 57 PCI percutaneous coronary 57 autologous SCT 57 nonoperative 57 Dabigatran 57 HF ACTION 57 carotid IMT 57 Arranon 57 clot busters 57 Lantus insulin 57 endotracheal intubation 57 AGGRASTAT ® 57 serum creatinine levels 57 adjuvant tamoxifen 57 beta carotene supplementation 57 ventilator weaning 57 non squamous NSCLC 57 oral clodronate 57 implantable cardioverter 57 antirheumatic 57 anticoagulant warfarin 57 surgical debulking 57 clinically localized prostate 57 mCRPC 57 protease inhibitor PI 57 platelet inhibitor 57 Voraxaze ™ 57 carotid endarterectomy 57 EGFR TKIs 57 REOPRO 57 acute coronary syndromes ACS 57 neurologic progression 57 Tasigna prolongs 57 biologic DMARD 57 ivabradine 57 Egrifta 57 oral Hycamtin 57 ARIXTRA R 57 MMRV vaccine 57 Roxana Mehran MD 57 IFN beta 57 dyslipidaemia 57 cytoreductive surgery 57 Gliadel Wafer 57 SGRQ 57 lethal arrhythmias 57 ejection fraction EF 57 antiangiogenic agents 57 colesevelam HCl 57 irbesartan 57 AutoloGel tm 57 cerebral oximetry 57 opioid naïve 57 fibrinolytic 57 meta regression 57 underwent CABG 57 nesiritide 57 lymph node dissection 57 oral RSD# 57 placebo dexamethasone 57 Zemplar 57 Multicenter Automatic Defibrillator Implantation 57 acute myocardial infarctions 57 endovascular aneurysm repair EVAR 57 BrachySil TM 57 Coronary artery bypass grafting 57 Antibiotic prophylaxis 57 Adjuvant chemotherapy 57 IVIG therapy 57 antiangiogenic agent 57 custirsen 57 antiretroviral naïve 57 gauge vitrectomy 57 metastatic lung cancer 57 allogeneic SCT 57 pCR 57 sociodemographic factors 57 VerifyNow P#Y# Test 57 oncological outcomes 57 somatostatin analogs 57 Fonarow 57 postintervention 57 AF ablation 57 posttreatment 57 moderate renal impairment 57 HIV coinfected 57 Targretin capsules 57 coinfected patients 57 thiazide diuretics 57 clinically meaningful improvement 57 EXJADE 57 Hepatocellular Carcinoma HCC 57 randomized controlled trials RCTs 57 nonsmall cell lung cancer 57 N telopeptide 57 thrombin inhibiting aptamer 57 multidose 57 eribulin mesylate 57 abdominal hysterectomy 57 nonsquamous 57 oral anticoagulants 57 oral FTY# 57 topical NSAIDs 57 NeuroStar TMS Therapy 57 AGGRASTAT R 57 postsurgical 57 viral kinetics 57 conventional antipsychotics 57 visilizumab 57 DESs 57 anticoagulant medications 57 ancrod 57 PROCHYMAL 57 silent ischemia 57 demonstrated clinically meaningful 57 INVEGA ® 57 QTinno 57 gemifloxacin 57 angiographic restenosis 57 chemotherapeutic regimens 57 RX ACCULINK 57 rindopepimut 57 Fibrillex TM 57 herpes zoster vaccine 56 LHRH agonists 56 mycophenolate mofetil MMF 56 Stent thrombosis 56 hematopoietic cancers 56 Coronary artery bypass 56 Zometa zoledronic acid 56 Powerlink stent graft 56 thetreatment 56 EndoTAGTM 1 56 transesophageal 56 virological suppression 56 rosuvastatin #mg 56 H. pylori eradication 56 nephron sparing surgery 56 virologic failure 56 thromboembolic 56 chemoradiation 56 idraparinux 56 colorectal liver metastases 56 PROLARIS 56 inpatient hospitalization 56 SLNB 56 epoetin alpha 56 MDCT scans 56 OnDose TM 56 hemoglobin A1C HbA1C 56 International Normalized Ratio 56 Renal Cell Carcinoma RCC 56 antihypertensive drugs 56 chronic angina 56 bisphosphonate therapy 56 SERCA2a 56 serum lipid levels 56 clot busting medications 56 COREG 56 selenium supplementation 56 Elevated triglycerides 56 Hypotension 56 CRBSIs 56 intravitreal triamcinolone 56 EECP ® therapy 56 EDSS scores 56 nonvertebral fractures 56 glargine 56 IVTA 56 β blocker 56 NLX P# 56 preventing venous thromboembolism 56 pulmonary exacerbations 56 generalizability 56 oral antidiabetic medication 56 #.#/#.# mmHg [001] 56 paliperidone ER 56 endovascular aneurysm repair 56 FOLFIRI alone 56 RX Acculink 56 peginterferon 56 electrophysiologic 56 Platelet counts 56 phosphate binders 56 spirometric 56 CLARITY study 56 Combination therapy 56 noninvasive ventilation 56 locoregional 56 Eli Lilly Cymbalta 56 urine albumin 56 INFUSE Bone Graft 56 warfarin dose 56 noscapine 56 Radiofrequency ablation 56 Zilver PTX stent